Geocann expands cannabis scientific research leadership with first human β-caryophyllene (BCP) published study demonstrating the safety and performance of novel formulation FORT COLLINS, Colo., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Geocann is proud to announce that the peer-reviewed journal, Molecules, has published the results of a randomized, double-blind, cross-over...

Theralogix is first to launch an NSF International certified CBD softgel powered by the clinically proven VESIsorb® technology FORT COLLINS, Colo., April 11, 2022 (GLOBE NEWSWIRE) -- Geocann and Theralogix are proud to announce the successful launch of a cannabidiol (CBD) and beta-caryophyllene (BCP) softgel formulation...